Leave Message

Porcine Circovirus Type 2 and Mycoplasma Hyopneumoniae Inactivated Vaccine (SH Strain + HN0613 Strain)

For the active immunisation of pigs over the age of two weeks in the prevention of viremia, aid in the reduction of virus shedding and aid in the reduction of lymphoid infection caused by porcine circovirus type 2 (PCV 2), and as an aid in the reduction of lung lesions due to Mycoplasma hyopneumoniae.

SUBSTANCE: Each dose(2ml)containing follows

Inactivated antigen of Porcine Circovirus Type 2 SH Strain ≥1.0×106.0TCID50

Inactivated antigen of Mycoplasma Hyopneumoniae HN0613 Strain ≥4.0×108CCU


20ml/bottle , 50ml/bottle ,100ml/bottle ,250ml/bottle

China Veterinary Drug Biological Product Approval No. :163001143


  • Intramuscular injection in the neck of pigs, the dosage is 2ml per head. Piglets are first vaccinated at age of 14 to 21 days and then repeated 2 weeks later.
  • Warm the vaccine to room temperature immediately prior to administration.
  • If the vaccine is discoloration, emulsification, bottle breakage, mixed foreign matter, etc., Do Not Use.
  • Use entire contents on the day when first opened


Initiate in China with fully independent R&D

Best Selling Products in this segment market in China

Antigen purification without interference and no compatibility concern

  • By optimizing the medium parameters and fermentation parameters, we have broken through the problem of low generation and high-density fermentation process of mycoplasma
  • Completely removed the residual circulating antibody in the serum for mycoplasma culture by tangential flow ultrafiltration + protein multiuser dispersion+other purification processes
  • Avoiding interference with circulating virus immunity and solving the compatibility problem of circulating and mycoplasma antigens
  • CCU level of 700L fermentation can reach up to 1×1010CCU/mL
  • 8 times higher than that of commercially available vaccine-content of mycoplasma in vaccine is ≥4×109.0CCU/head
  • Cultivated antigen with PK-B1 susceptible clone cells line can boost the Porcine circovirus type 2 content in the vaccine ≥1.0×107.0TCID50 /head.

Patented Aquae adjuvant FreemixTM for simultaneous application of dual antigens

This vaccine is accompanied by an internationally advanced aquae adjuvant FreemixTM which is prepared by colloidal polymer cross-linked copolymer into nano-microspheres with a spatial reticulation structure inside the microspheres, which has high efficiency in adsorbing antigens, thus realizing long-lasting and slow release, and can efficiently recruit immune cells.

Contains innovative FreemixTM adjuvant technology that provide easy vaccine absorption, raid onset of immunity-7 days post immunization as well as <0.01% adverse reaction in pigs. Provide at least 24 weeks of immunity to last through market

8 effectiveness proved with customs

  • Reduce the use of antibiotics by 10%-20%
  • Post-immunization stress reduction by 2-3 times
  • Reduce the incidence of respiratory diseases by 20%
  • Decrease labor intensity
  • Improve daily weight gain by 30-70g
  • Improve herd uniformity by 20%.
  • Increase survival rate by 2-4%,
  • Increase efficiency
*Use only under the guidance of a veterinarian
Leave Message
Home Product About Contact